Captor Therapeutics Spolka Akcyjna (WSE:CTX)
Poland · Delayed Price · Currency is PLN 38.00
-0.20 (-0.52%)
Oct 10, 2025, 5:00 PM CET
WSE:CTX Revenue
Captor Therapeutics Spolka Akcyjna had revenue of 2.01M PLN in the quarter ending June 30, 2025, a decrease of -58.44%. This brings the company's revenue in the last twelve months to 11.10M, down -40.45% year-over-year. In the year 2024, Captor Therapeutics Spolka Akcyjna had annual revenue of 15.83M with 19.88% growth.
Revenue (ttm)
11.10M
Revenue Growth
-40.45%
P/S Ratio
18.93
Revenue / Employee
n/a
Employees
91
Market Cap
210.09M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 15.83M | 2.62M | 19.88% |
| Dec 31, 2023 | 13.20M | 4.04M | 44.15% |
| Dec 31, 2022 | 9.16M | 5.17M | 129.75% |
| Dec 31, 2021 | 3.99M | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Diagnostyka | 2.17B |
| NEUCA | 13.04B |
| Synektik Spólka Akcyjna | 623.20M |
| Voxel | 560.38M |
| Celon Pharma | 206.22M |
| Selvita | 373.90M |
| Centrum Medyczne ENEL-MED | 789.78M |
| Ryvu Therapeutics | 130.10M |